Acetylcholine for male LUTS

Steven J. Weissbart; Bilal Chughtai; Dean Elterman; Richard Lee; Alexis Te; Steven Kaplan

doi:10.1007/s11934-012-0276-7

Acetylcholine for male LUTS

Steven J. Weissbart, Bilal Chughtai, Dean Elterman, Richard Lee, Alexis Te, Steven Kaplan

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

In this review, we present the evidence on the safety and efficacy of anticholinergic therapy for men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) and emphasize the data published over the past year. This review discusses two classes of medications whose mechanism of action attenuates the effect of acetylcholine on the LUT: anticholinergics and botulinum toxin. We review the randomized controlled trials that investigate the efficacy and side effects of anticholinergics when used in men with LUTS secondary to BPH. We emphasize new studies and developments that have been made in the past year.

Original language	English
Pages (from-to)	413-419
Number of pages	7
Journal	Current Urology Reports
Volume	13
Issue number	6
DOIs	https://doi.org/10.1007/s11934-012-0276-7
State	Published - Dec 2012
Externally published	Yes

Keywords

Acetylcholine
Anticholinergic therapy
Benign prostatic hyperplasia
Botulinum toxin
Lower urinary tracts symptoms
Overactive bladder

Access to Document

10.1007/s11934-012-0276-7

Cite this

@article{681fa3a7bf0948d99b59f3ff1394607d,

title = "Acetylcholine for male LUTS",

abstract = "In this review, we present the evidence on the safety and efficacy of anticholinergic therapy for men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) and emphasize the data published over the past year. This review discusses two classes of medications whose mechanism of action attenuates the effect of acetylcholine on the LUT: anticholinergics and botulinum toxin. We review the randomized controlled trials that investigate the efficacy and side effects of anticholinergics when used in men with LUTS secondary to BPH. We emphasize new studies and developments that have been made in the past year.",

keywords = "Acetylcholine, Anticholinergic therapy, Benign prostatic hyperplasia, Botulinum toxin, Lower urinary tracts symptoms, Overactive bladder",

author = "Weissbart, {Steven J.} and Bilal Chughtai and Dean Elterman and Richard Lee and Alexis Te and Steven Kaplan",

year = "2012",

month = dec,

doi = "10.1007/s11934-012-0276-7",

language = "English",

volume = "13",

pages = "413--419",

journal = "Current Urology Reports",

issn = "1527-2737",

publisher = "Current Science, Inc.",

number = "6",

}

TY - JOUR

T1 - Acetylcholine for male LUTS

AU - Weissbart, Steven J.

AU - Chughtai, Bilal

AU - Elterman, Dean

AU - Lee, Richard

AU - Te, Alexis

AU - Kaplan, Steven

PY - 2012/12

Y1 - 2012/12

N2 - In this review, we present the evidence on the safety and efficacy of anticholinergic therapy for men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) and emphasize the data published over the past year. This review discusses two classes of medications whose mechanism of action attenuates the effect of acetylcholine on the LUT: anticholinergics and botulinum toxin. We review the randomized controlled trials that investigate the efficacy and side effects of anticholinergics when used in men with LUTS secondary to BPH. We emphasize new studies and developments that have been made in the past year.

AB - In this review, we present the evidence on the safety and efficacy of anticholinergic therapy for men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) and emphasize the data published over the past year. This review discusses two classes of medications whose mechanism of action attenuates the effect of acetylcholine on the LUT: anticholinergics and botulinum toxin. We review the randomized controlled trials that investigate the efficacy and side effects of anticholinergics when used in men with LUTS secondary to BPH. We emphasize new studies and developments that have been made in the past year.

KW - Acetylcholine

KW - Anticholinergic therapy

KW - Benign prostatic hyperplasia

KW - Botulinum toxin

KW - Lower urinary tracts symptoms

KW - Overactive bladder

UR - http://www.scopus.com/inward/record.url?scp=84877125823&partnerID=8YFLogxK

U2 - 10.1007/s11934-012-0276-7

DO - 10.1007/s11934-012-0276-7

M3 - Article

C2 - 22923069

AN - SCOPUS:84877125823

SN - 1527-2737

VL - 13

SP - 413

EP - 419

JO - Current Urology Reports

JF - Current Urology Reports

IS - 6

ER -

Acetylcholine for male LUTS

Abstract

Keywords

Access to Document

Fingerprint

Cite this